KR100396168B1 - 4″-치환된-9-데옥소-9ａ-아자-9ａ-호모에리트로마이신 Ａ유도체 - Google Patents

4″-치환된-9-데옥소-9ａ-아자-9ａ-호모에리트로마이신 Ａ유도체 Download PDF

Info

Publication number
KR100396168B1
KR100396168B1 KR10-1999-7011642A KR19997011642A KR100396168B1 KR 100396168 B1 KR100396168 B1 KR 100396168B1 KR 19997011642 A KR19997011642 A KR 19997011642A KR 100396168 B1 KR100396168 B1 KR 100396168B1
Authority
KR
South Korea
Prior art keywords
compound
formula
hydroxy
alkyl
optionally
Prior art date
Application number
KR10-1999-7011642A
Other languages
English (en)
Korean (ko)
Other versions
KR20010013632A (ko
Inventor
브라이언 스코트 브롱크
마이클 앤쏘니 레타빅
타꾸시 가네꼬
빙웨이 베라 양
에드워드 앨런 글래이저
헹미아오 쳉
Original Assignee
화이자 프로덕츠 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21959336&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR100396168(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 화이자 프로덕츠 인크. filed Critical 화이자 프로덕츠 인크.
Publication of KR20010013632A publication Critical patent/KR20010013632A/ko
Application granted granted Critical
Publication of KR100396168B1 publication Critical patent/KR100396168B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KR10-1999-7011642A 1997-06-11 1998-05-29 4″-치환된-9-데옥소-9ａ-아자-9ａ-호모에리트로마이신 Ａ유도체 KR100396168B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4934897P 1997-06-11 1997-06-11
US60/049,348 1997-06-11

Publications (2)

Publication Number Publication Date
KR20010013632A KR20010013632A (ko) 2001-02-26
KR100396168B1 true KR100396168B1 (ko) 2003-08-27

Family

ID=21959336

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-1999-7011642A KR100396168B1 (ko) 1997-06-11 1998-05-29 4″-치환된-9-데옥소-9ａ-아자-9ａ-호모에리트로마이신 Ａ유도체

Country Status (50)

Country Link
US (4) US6420536B1 (US06559137-20030506-C00071.png)
EP (1) EP0988310B9 (US06559137-20030506-C00071.png)
JP (2) JP3315704B2 (US06559137-20030506-C00071.png)
KR (1) KR100396168B1 (US06559137-20030506-C00071.png)
CN (4) CN101691390A (US06559137-20030506-C00071.png)
AP (1) AP1231A (US06559137-20030506-C00071.png)
AR (1) AR013086A1 (US06559137-20030506-C00071.png)
AT (1) ATE251173T1 (US06559137-20030506-C00071.png)
AU (1) AU749816B2 (US06559137-20030506-C00071.png)
BG (1) BG64391B1 (US06559137-20030506-C00071.png)
BR (1) BRPI9810519B8 (US06559137-20030506-C00071.png)
CA (1) CA2293823C (US06559137-20030506-C00071.png)
CO (1) CO4950611A1 (US06559137-20030506-C00071.png)
CZ (1) CZ298556B6 (US06559137-20030506-C00071.png)
DE (2) DE122004000018I2 (US06559137-20030506-C00071.png)
DK (1) DK0988310T3 (US06559137-20030506-C00071.png)
DZ (1) DZ2514A1 (US06559137-20030506-C00071.png)
EA (1) EA002441B1 (US06559137-20030506-C00071.png)
EG (1) EG24081A (US06559137-20030506-C00071.png)
ES (1) ES2205487T3 (US06559137-20030506-C00071.png)
FR (1) FR04C0013I2 (US06559137-20030506-C00071.png)
GT (1) GT199800077A (US06559137-20030506-C00071.png)
HK (3) HK1028048A1 (US06559137-20030506-C00071.png)
HN (1) HN1998000086A (US06559137-20030506-C00071.png)
HR (1) HRP980314B1 (US06559137-20030506-C00071.png)
HU (2) HU228005B1 (US06559137-20030506-C00071.png)
ID (1) ID22992A (US06559137-20030506-C00071.png)
IL (1) IL132809A0 (US06559137-20030506-C00071.png)
IS (1) IS1998B (US06559137-20030506-C00071.png)
LU (1) LU91076I9 (US06559137-20030506-C00071.png)
MA (1) MA24564A1 (US06559137-20030506-C00071.png)
ME (1) ME00876B (US06559137-20030506-C00071.png)
MY (1) MY123354A (US06559137-20030506-C00071.png)
NL (1) NL300150I2 (US06559137-20030506-C00071.png)
NO (1) NO316911B1 (US06559137-20030506-C00071.png)
NZ (2) NZ500660A (US06559137-20030506-C00071.png)
OA (1) OA11224A (US06559137-20030506-C00071.png)
PA (1) PA8452201A1 (US06559137-20030506-C00071.png)
PE (1) PE79699A1 (US06559137-20030506-C00071.png)
PL (1) PL191601B1 (US06559137-20030506-C00071.png)
PT (1) PT988310E (US06559137-20030506-C00071.png)
RS (1) RS49675B (US06559137-20030506-C00071.png)
SI (1) SI0988310T1 (US06559137-20030506-C00071.png)
SK (1) SK284171B6 (US06559137-20030506-C00071.png)
TN (1) TNSN98082A1 (US06559137-20030506-C00071.png)
TW (1) TW472060B (US06559137-20030506-C00071.png)
UA (1) UA67744C2 (US06559137-20030506-C00071.png)
UY (1) UY25040A1 (US06559137-20030506-C00071.png)
WO (1) WO1998056802A1 (US06559137-20030506-C00071.png)
ZA (1) ZA985017B (US06559137-20030506-C00071.png)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
US6339063B1 (en) 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
EP1779853A3 (en) * 1997-09-10 2010-01-27 Merial Ltd. 9a-azalides as veterinary antimicrobial agents
NZ502861A (en) * 1997-09-10 2001-03-30 Merck & Co Inc Method of treating livestock bacterial respiratory or enteric infections using 9a-azalides
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
EP1437360A3 (en) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11 Carbamates of macrolide antibacterials
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
CA2411293A1 (en) * 1999-01-28 2000-07-28 Pfizer Products Inc. Novel azalides and methods of making same
PT1189912E (pt) * 1999-05-18 2008-05-16 Pfizer Prod Inc Novas formas cristalinas de um antibiótico macrólido
PL352720A1 (en) * 1999-05-24 2003-09-08 Pfizer Products Inc. 13-methyl-erythromycin derivatives
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
US6764996B1 (en) 1999-08-24 2004-07-20 Abbott Laboratories 9a-azalides with antibacterial activity
JP2003507487A (ja) * 1999-08-24 2003-02-25 アボット・ラボラトリーズ 抗菌活性を有する９ａ−アザライド類
US6608033B1 (en) 1999-08-27 2003-08-19 Pfizer Inc. Treatment or prevention of coccidiosis
EP1250343B1 (en) * 2000-01-27 2003-06-25 Pfizer Products Inc. Azalide antibiotic compositions
YU78702A (sh) * 2000-04-27 2005-11-28 Pfizer Products Inc. Upotreba azalid antibiotika za lečenje ili prevenciju bakterijske infekcije ili infekcije izazvane protozoama kod sisara
IL158059A0 (en) * 2001-04-27 2004-03-28 Pfizer Prod Inc Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
AU2002317415A1 (en) * 2001-08-01 2003-02-17 Pfizer Products Inc. Azalide antibiotic compositions
WO2004080391A2 (en) 2003-03-10 2004-09-23 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
WO2005030227A1 (en) 2003-09-23 2005-04-07 Enanta Pharmaceuticals, Inc. 9a, 11-3C-BICYCLIC 9a-AZALIDE DERIVATIVES
MXPA06005639A (es) * 2003-11-21 2006-08-17 Pfizer Prod Inc Adyuvante antimicrobiano.
BRPI0508830B8 (pt) * 2004-03-16 2021-05-25 Boehringer Ingelheim Int derivados de benzeno substituídos por glucopiranosila, medicamentos contendo esses compostos, seu uso e processo para sua fabricação
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7402568B2 (en) 2004-09-29 2008-07-22 Enanta Pharmaceuticals, Inc. Bicyclic 9a-azalide derivatives
US7767797B1 (en) * 2004-09-30 2010-08-03 Synovo Gmbh Macrocyclic compounds and methods of use thereof
US7271155B2 (en) 2005-01-07 2007-09-18 Enanta Pharmaceuticals, Inc. 9A, 11-2C-bicyclic 9a-azalide derivatives
JP2008526948A (ja) * 2005-01-14 2008-07-24 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 抗マラリア活性を有する９ａ−カルバモイルおよびチオカルバモイルアザライド
CN105732745A (zh) * 2007-10-25 2016-07-06 森普拉制药公司 大环内酯类抗菌剂的制备方法
JP5711135B2 (ja) * 2008-10-24 2015-04-30 センプラ ファーマシューティカルズ，インコーポレイテッド 胃腸疾患を治療するための方法
US9937194B1 (en) * 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
JP5711352B2 (ja) 2010-03-22 2015-04-30 センプラ ファーマシューティカルズ，インコーポレイテッド マクロライドの結晶形、およびその使用
JP6184319B2 (ja) 2010-05-20 2017-08-23 センプラ ファーマシューティカルズ，インコーポレイテッド マクロライド類およびケトライド類ならびにその中間体を調製するための工程
JP6042334B2 (ja) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
EP2619214B1 (en) 2010-09-20 2014-12-24 Novartis AG Novel process for the preparation of 9-deoxo-9a-aza-9a-homoerythromycin a modified in the c-4'' of the cladinose ring by an epoxide group
EP2625185A4 (en) * 2010-10-10 2014-03-26 Synovo Gmbh INFLAMMATORY MAKROLIDE
CN102993250B (zh) * 2011-07-06 2016-02-10 洛阳惠中兽药有限公司 C-3取代的-9-脱氧-9a-氮杂-9a-高红霉素a衍生物
CN102260306B (zh) * 2011-07-22 2012-07-18 山东鲁抗舍里乐药业有限公司 一种制备泰拉霉素的方法
WO2013013834A1 (en) 2011-07-27 2013-01-31 Farma Grs, D.O.O. New crystalline forms of tulathromycin
JP6208742B2 (ja) 2012-03-27 2017-10-04 センプラ ファーマシューティカルズ，インコーポレイテッド マクロライド抗生物質を投与するための非経口製剤
CN102786569B (zh) * 2012-09-07 2016-12-07 安徽中升药业有限公司 泰拉霉素中间体及其制备方法与泰拉霉素的制备方法
CN105163785A (zh) 2013-03-14 2015-12-16 森普拉制药公司 用于治疗呼吸道疾病的方法及其制剂
MX356772B (es) 2013-03-15 2018-06-13 Cempra Pharmaceuticals Inc Procesos convergentes para la preparacion de agentes antibacterianos macrolidos.
SI3027634T1 (sl) * 2013-07-31 2018-10-30 Farma Grs, D.O.O. Proces za pripravo tulatromicina
CN103497227B (zh) * 2013-09-13 2015-09-30 青岛科技大学 一种泰拉菌素中间体的制备方法
CN104725446B (zh) * 2015-03-26 2017-10-27 宁夏泰瑞制药股份有限公司 一种从泰拉霉素粗品中分离泰拉霉素a和泰拉霉素b的方法
CN104861018A (zh) * 2015-06-17 2015-08-26 瑞普（天津）生物药业有限公司 一种泰拉菌素的制备方法
CN105646617A (zh) * 2016-01-21 2016-06-08 杭州海尔希畜牧科技有限公司 一种制备泰拉霉素的方法
FR3048612B1 (fr) * 2016-03-14 2020-10-02 Septeos Tulathromycine potentialisee
CN106046077B (zh) * 2016-08-04 2019-07-26 湖北美天生物科技股份有限公司 一种泰拉霉素a的合成方法
CN108003207B (zh) 2017-12-19 2019-05-10 海门慧聚药业有限公司 制备泰拉霉素的方法
CN111087433B (zh) * 2018-10-23 2023-03-21 湖北美天生物科技股份有限公司 一种泰拉霉素中间体的制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60231691A (ja) * 1984-04-13 1985-11-18 フアイザー・インコーポレーテツド ９ａ‐アザ‐９ａ‐ホモエリスロマイシン誘導体
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
CA2064634C (en) 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
US5226958A (en) * 1991-04-11 1993-07-13 Pacemark, Inc. Sealant for pneumatic inner tubes and tubeless tires
EP0549040A1 (en) * 1991-12-20 1993-06-30 Merck & Co. Inc. Methods of making 4" derivatives of 9-deoxo-8a-aza-8a-alkyl-8a-homoerythromycin A
HN1998000086A (es) 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
UA70972C2 (uk) 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60231691A (ja) * 1984-04-13 1985-11-18 フアイザー・インコーポレーテツド ９ａ‐アザ‐９ａ‐ホモエリスロマイシン誘導体
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin

Also Published As

Publication number Publication date
ZA985017B (en) 1999-12-17
EA199901015A1 (ru) 2000-06-26
HK1028048A1 (en) 2001-02-02
EP0988310B1 (en) 2003-10-01
EA002441B1 (ru) 2002-04-25
IS1998B (is) 2005-03-15
US6420536B1 (en) 2002-07-16
CO4950611A1 (es) 2000-09-01
NZ514871A (en) 2003-08-29
BRPI9810519B1 (pt) 2012-02-22
CZ442199A3 (cs) 2000-07-12
DZ2514A1 (fr) 2003-02-01
PL337505A1 (en) 2000-08-28
UY25040A1 (es) 2000-09-29
UA67744C2 (uk) 2004-07-15
CN1172947C (zh) 2004-10-27
BRPI9810519A (pt) 2000-09-19
MA24564A1 (fr) 1998-12-31
ATE251173T1 (de) 2003-10-15
JP3315704B2 (ja) 2002-08-19
CN1793155B (zh) 2010-05-12
HK1068893A1 (en) 2005-07-29
CN1793155A (zh) 2006-06-28
RS49675B (sr) 2007-11-15
LU91076I2 (fr) 2004-07-05
DE69818665D1 (de) 2003-11-06
HRP980314A2 (en) 1999-04-30
NO316911B1 (no) 2004-06-21
BG103945A (en) 2000-07-31
PA8452201A1 (es) 2000-05-24
HK1088014A1 (en) 2006-10-27
HUP0002209A2 (hu) 2000-12-28
AU7347598A (en) 1998-12-30
NZ500660A (en) 2002-03-01
AU749816B2 (en) 2002-07-04
SK284171B6 (sk) 2004-10-05
AP9801255A0 (en) 1998-06-30
NO996106D0 (no) 1999-12-10
JP2002316933A (ja) 2002-10-31
LU91076I9 (en) 2018-07-02
KR20010013632A (ko) 2001-02-26
CN1566129A (zh) 2005-01-19
EP0988310A1 (en) 2000-03-29
YU58699A (US06559137-20030506-C00071.png) 2002-08-12
AP1231A (en) 2003-12-11
IL132809A0 (en) 2001-03-19
US20040180842A1 (en) 2004-09-16
HUS1200028I1 (hu) 2016-08-29
HN1998000086A (es) 1999-03-08
NL300150I2 (nl) 2004-09-01
CA2293823A1 (en) 1998-12-17
SI0988310T1 (en) 2004-02-29
US6936592B2 (en) 2005-08-30
FR04C0013I2 (US06559137-20030506-C00071.png) 2005-10-21
US20040023896A1 (en) 2004-02-05
CZ298556B6 (cs) 2007-11-07
CA2293823C (en) 2004-02-17
PE79699A1 (es) 1999-08-25
DE69818665T2 (de) 2004-04-29
US20020061858A1 (en) 2002-05-23
PL191601B1 (pl) 2006-06-30
NO996106L (no) 2000-02-10
DE122004000018I2 (de) 2011-01-13
WO1998056802A1 (en) 1998-12-17
US6777393B2 (en) 2004-08-17
BG64391B1 (bg) 2004-12-30
FR04C0013I1 (US06559137-20030506-C00071.png) 2004-06-11
ME00876B (me) 2012-06-20
DK0988310T3 (da) 2003-12-15
NL300150I1 (nl) 2004-08-02
HRP980314B1 (en) 2004-04-30
CN101691390A (zh) 2010-04-07
TNSN98082A1 (fr) 2005-03-15
AR013086A1 (es) 2000-12-13
EP0988310B9 (en) 2006-03-08
GT199800077A (es) 1999-12-02
EG24081A (en) 2008-05-11
HUP0002209A3 (en) 2003-05-28
ES2205487T3 (es) 2004-05-01
OA11224A (en) 2003-07-16
SK168399A3 (en) 2000-11-07
CN1259136A (zh) 2000-07-05
ID22992A (id) 1999-12-23
HU228005B1 (en) 2012-08-28
TW472060B (en) 2002-01-11
MY123354A (en) 2006-05-31
PT988310E (pt) 2003-12-31
DE122004000018I1 (de) 2004-09-30
JP2000514098A (ja) 2000-10-24
IS5252A (is) 1999-11-16
BRPI9810519B8 (pt) 2022-11-16
CN1243766C (zh) 2006-03-01

Similar Documents

Publication Publication Date Title
KR100396168B1 (ko) 4″-치환된-9-데옥소-9ａ-아자-9ａ-호모에리트로마이신 Ａ유도체
KR100369959B1 (ko) Ｃ-4″-치환된-마크롤리드 유도체
US6576749B2 (en) C-4″-substituted macrolide derivatives
EP0988308A1 (en) 9-oxime erythromycin derivatives
US6043227A (en) C11 carbamates of macrolide antibacterials
US20020151507A1 (en) 9-oxime erythromycin derivatives
MXPA99011496A (en) C-4''-substituted macrolide derivatives
CZ438999A3 (cs) C-4"- substituované makrolidové deriváty
MXPA99011495A (en) 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20120727

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20130729

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20140730

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20160629

Year of fee payment: 14

FPAY Annual fee payment

Payment date: 20170629

Year of fee payment: 15

FPAY Annual fee payment

Payment date: 20180628

Year of fee payment: 16

EXPY Expiration of term